These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18500344)

  • 21. Transcriptional Regulation of Atp-Dependent Chromatin Remodeling Factors: Smarcal1 and Brg1 Mutually Co-Regulate Each Other.
    Haokip DT; Goel I; Arya V; Sharma T; Kumari R; Priya R; Singh M; Muthuswami R
    Sci Rep; 2016 Feb; 6():20532. PubMed ID: 26843359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
    Rosson GB; Bartlett C; Reed W; Weissman BE
    J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal activity-induced BRG1 phosphorylation regulates enhancer activation.
    Kim B; Luo Y; Zhan X; Zhang Z; Shi X; Yi J; Xuan Z; Wu J
    Cell Rep; 2021 Jul; 36(2):109357. PubMed ID: 34260936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of a distal enhancer in the transcriptional responsiveness of the human CD200 gene to interferon-gamma and tumor necrosis factor-alpha.
    Chen Z; Marsden PA; Gorczynski RM
    Mol Immunol; 2009 Jun; 46(10):1951-63. PubMed ID: 19386363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancer-promoter communication mediated by Chip during Pannier-driven proneural patterning is regulated by Osa.
    Heitzler P; Vanolst L; Biryukova I; Ramain P
    Genes Dev; 2003 Mar; 17(5):591-6. PubMed ID: 12629041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes.
    Zika E; Ting JP
    Curr Opin Immunol; 2005 Feb; 17(1):58-64. PubMed ID: 15653312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of MHC-II and CIITA genes.
    Wright KL; Ting JP
    Trends Immunol; 2006 Sep; 27(9):405-12. PubMed ID: 16870508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
    Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
    Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRG1 directly regulates nucleosome structure and chromatin looping of the alpha globin locus to activate transcription.
    Kim SI; Bresnick EH; Bultman SJ
    Nucleic Acids Res; 2009 Oct; 37(18):6019-27. PubMed ID: 19696073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ChromaSig: a probabilistic approach to finding common chromatin signatures in the human genome.
    Hon G; Ren B; Wang W
    PLoS Comput Biol; 2008 Oct; 4(10):e1000201. PubMed ID: 18927605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRG1 regulates NOX gene transcription in endothelial cells and contributes to cardiac ischemia-reperfusion injury.
    Li Z; Zhang X; Liu S; Zeng S; Yu L; Yang G; Guo J; Xu Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3477-3486. PubMed ID: 30293567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE; Yu HN; Yoon CH; Bae YS
    Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic BRG1 recruitment during T helper differentiation and activation reveals distal regulatory elements.
    De S; Wurster AL; Precht P; Wood WH; Becker KG; Pazin MJ
    Mol Cell Biol; 2011 Apr; 31(7):1512-27. PubMed ID: 21262765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin-Remodeling Factor BRG1 Is a Negative Modulator of
    Brar HK; Roy G; Kanojia A; Madan E; Madhubala R; Muthuswami R
    Front Cell Infect Microbiol; 2022; 12():860058. PubMed ID: 35433496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo.
    Johnson TA; Chereji RV; Stavreva DA; Morris SA; Hager GL; Clark DJ
    Nucleic Acids Res; 2018 Jan; 46(1):203-214. PubMed ID: 29126175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation.
    Schmiedel D; Hezroni H; Hamburg A; Shulman Z
    Front Immunol; 2021; 12():705848. PubMed ID: 34539636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of an scFv targeting BRG1 using phage display with characterization by AFM.
    Marcus WD; Wang H; Lohr D; Sierks MR; Lindsay SM
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1123-9. PubMed ID: 16513088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.